Overview
- 75 inspections across 72 sites are on record.
- 14 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
75
Sites
72
Observations
14
Career since
Jan 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| ICON PLC | 20 May 2026 | Human Drugs | |
| Amy T. Waldman, MD, MSCE | 24 Apr 2026 | Human Drugs | |
| Cameron Olezene, M.D. | 1 Apr 2026 | Human Drugs | On file |
| Qiagen Manchester Ltd. | 24 Feb 2026 | Medical Devices & Rad Health | |
| Steven Feigenberg, M.D | 30 Jan 2026 | Human Drugs |
Sites inspected
ICON PLCBlue Bell, United States1 insp.
Amy T. Waldman, MD, MSCEPhiladelphia, United States1 insp.
Cameron Olezene, M.D.Plymouth Meeting, United States1 insp.
Qiagen Manchester Ltd.Manchester, United Kingdom1 insp.
Steven Feigenberg, M.DPhiladelphia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Anastasia I Offordile11 shared
Gabrielle J Swain6 shared
Christopher Bastedo3 shared
Sam Pepe2 shared
Stephanie C Mangigian2 shared
Kelly N Kerr1 shared
Byungja E Marciante1 shared
Joseph L Despins1 shared
Full investigator report
Get the verbatim findings behind Anastasia I Onuorah's 14 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site